Literature DB >> 23275435

Childhood rubella encephalitis: diagnosis, management, and outcome.

Anis Chaari1, Mabrouk Bahloul, Lamia Berrajah, Sahar Ben Kahla, Nourhene Gharbi, Hela Karray, Mounir Bouaziz.   

Abstract

We to report clinical biological and radiologic features of rubella encephalitis in childhood and assess its prognostic impact. Our retrospective study was conducted in an intensive care unit of a university hospital in Sfax, Tunisia. Twenty-one children (age range, 1-15 years) were included. Median age was 9 years (lower and upper quartiles, 7-11 years). On admission, generalized maculopapular eruption was found in 17 cases (81%). Median Glasgow Coma Scale score was 7 (lower and upper quartiles, 7-8). Twenty patients (95.2%) experienced at least 1 episode of seizures. Sixteen patients (76.2%) developed a status epilepticus. The result for enzyme-linked immunosorbent assay detecting anti-rubella immunoglobulin (M) was positive in the serum and in the cerebrospinal fluid samples for all our patients. Magnetic resonance imaging (MRI) of the brain was performed on admission for 3 patients (14.3%) and within a median of 4 days (lower and upper quartiles, 2-6 days) for 8 patients. The test was normal in 6 cases. Two deaths were recorded (9.5%). Survivors had no neurological sequelae 6 months after intensive care unit discharge.

Entities:  

Keywords:  diagnosis; management; outcome; rubella encephalitis

Mesh:

Substances:

Year:  2012        PMID: 23275435     DOI: 10.1177/0883073812469443

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

Review 1.  Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?

Authors:  Dina B Mahmoud; Zayyanu Shitu; Ahmed Mostafa
Journal:  J Genet Eng Biotechnol       Date:  2020-07-28

Review 2.  Rubella virus-associated chronic inflammation in primary immunodeficiency diseases.

Authors:  Ludmila Perelygina; Joseph Icenogle; Kathleen E Sullivan
Journal:  Curr Opin Allergy Clin Immunol       Date:  2020-12

3.  Acute Encephalitis with Atypical Presentation of Rubella in Family Cluster, India.

Authors:  Sumit D Bharadwaj; Rima R Sahay; Pragya D Yadav; Sara Dhanawade; Atanu Basu; Virendra K Meena; Suji George; Rekha Damle; Gajanan N Sapkal
Journal:  Emerg Infect Dis       Date:  2018-10       Impact factor: 6.883

4.  Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency.

Authors:  Ludmila Perelygina; Timo Hautala; Mikko Seppänen; Adebola Adebayo; Kathleen E Sullivan; Joseph Icenogle
Journal:  Antiviral Res       Date:  2017-09-30       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.